EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Differential Effects of Intravenous Versus Intracoronary Adenosine on Non‐Culprit Lesion Assessment Following Acute Coronary Syndrome

Jonathan Los iD, Frans B Mensink iD, Guus A de Waard iD, Lokien X van Nunen iD, Mohamed M Reda Morsy iD, Peter Damman iD, Tim J F Ten Cate iD, Cyril Camaro iD, Aukelien C Dimitriu-Leen, Marleen H van Wely iD, Aysun Cetinyurek-Yavuz iD, Niels van Royen iD und 1 weitere

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.125.045537 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Jonathan Los und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Radboud University Medical Center Nijmegen The Netherlands. Hauptthemen laut MEDLINE: Adenosine, Acute Coronary Syndrome, Fractional Flow Reserve, Myocardial, Vasodilator Agents. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

During acute coronary syndrome ( ACS ), the validity of initial non‐culprit fractional flow reserve ( FFR ) measurements remains controversial because of microvascular dysfunction and potential diminished adenosine response. Because the hyperemic effects of adenosine have been predominantly studied in stable patients, and high‐dose intracoronary administration may produce stronger hyperemia than intravenous delivery, we compared non‐culprit FFR between the acute and stabilized phases of ACS using both administration routes.

Methods

Patients presenting with ACS underwent repeated physiological assessment of relevant non‐culprit lesions using both intracoronary adenosine boluses (≥100 μg) and intravenous adenosine (140 μg/kg/min) during index hospitalization and at 12‐week follow‐up.

Results

A total of 53 patients (mean age 65.1±9.3 years, 7 [13.2%] women) were included in the current analysis. A significant interaction between the route of adenosine administration and change in FFR was found ( P =0.035). Baseline FFR was lower when measured with intracoronary adenosine (mean difference: −0.02, 95% CI , −0.03 to −0.01). Over time, FFR measured with intravenous adenosine decreased (mean change: −0.02, 95% CI, −0.04 to −0.00), while intracoronary adenosine showed stable values (mean change: −0.00, 95% CI, −0.02 to 0.01). Concurrently, more patients were initially classified as having a non‐flow‐limiting lesion with intravenous adenosine (27 [50.9%] versus 15 [28.3%], P =0.008), which was no longer evident at follow‐up ( P =0.146). No significant change in microvascular function was observed.

Conclusions

During ACS , adequate intracoronary adenosine boluses elicit a stronger hyperemic response than intravenous adenosine administration, yielding lower initial FFR values that remain stable over time. Further research is warranted to investigate the dose‐dependent hyperemic effects of intravenous adenosine during the acute phase of ACS .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenosineAcute Coronary SyndromeFractional Flow Reserve, MyocardialVasodilator AgentsCoronary VesselsHumansFemaleMaleAgedMiddle AgedHyperemiaAdministration, IntravenousInfusions, IntravenousCoronary AngiographyCardiac Catheterization

Stichwörter der Autor:innen

acute coronary syndrome (ACS)adenosinefractional flow reserve (FFR)microvascular functionnon‐culprit vessels

Substanzen

AdenosineVasodilator Agents

Autor:innen und Institutionen

  • Department of Cardiology Radboud University Medical Center Nijmegen The Netherlands.
  • Department of Cardiology, Faculty of Medicine Assiut University Assiut Egypt.
  • Department of IQ Health Radboud University Medical Center Nijmegen The Netherlands.

ORCID-Profile: Jonathan Los, Frans B Mensink, Guus A de Waard, Lokien X van Nunen, Mohamed M Reda Morsy, Peter Damman, Tim J F Ten Cate, Cyril Camaro, Marleen H van Wely, Aysun Cetinyurek-Yavuz, Niels van Royen, Robert-Jan M van Geuns

Zitieren

APA

Los, J., Mensink, F. B., de Waard, G. A., van Nunen, L. X., Reda Morsy, M. M., Damman, P., Ten Cate, T. J. F., Camaro, C., Dimitriu-Leen, A. C., van Wely, M. H., Cetinyurek-Yavuz, A., van Royen, N., & van Geuns, R. M. (2025). Differential Effects of Intravenous Versus Intracoronary Adenosine on Non‐Culprit Lesion Assessment Following Acute Coronary Syndrome. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.045537

Vancouver

Los J, Mensink FB, de Waard GA, van Nunen LX, Reda Morsy MM, Damman P, et al. Differential Effects of Intravenous Versus Intracoronary Adenosine on Non‐Culprit Lesion Assessment Following Acute Coronary Syndrome. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.045537

BibTeX
@article{Los2025,
  author = {Los, Jonathan and Mensink, Frans B and de Waard, Guus A and van Nunen, Lokien X and Reda Morsy, Mohamed M and Damman, Peter and Ten Cate, Tim J F and Camaro, Cyril and Dimitriu-Leen, Aukelien C and van Wely, Marleen H and Cetinyurek-Yavuz, Aysun and van Royen, Niels and van Geuns, Robert-Jan M},
  title = {Differential Effects of Intravenous Versus Intracoronary Adenosine on Non‐Culprit Lesion Assessment Following Acute Coronary Syndrome},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.125.045537}
}
Kostenlos starten →